Gene/Proteome Database (LMPD)
LMPD ID
LMP000398
Gene ID
Species
Homo sapiens (Human)
Gene Name
apolipoprotein A-II
Gene Symbol
Synonyms
Apo-AII; ApoA-II; apoAII
Alternate Names
apolipoprotein A-II; apolipoprotein A2
Chromosome
1
Map Location
1q23.3
Summary
This gene encodes apolipoprotein (apo-) A-II, which is the second most abundant protein of the high density lipoprotein particles. The protein is found in plasma as a monomer, homodimer, or heterodimer with apolipoprotein D. Defects in this gene may result in apolipoprotein A-II deficiency or hypercholesterolemia. [provided by RefSeq, Jul 2008]
Orthologs
Proteins
apolipoprotein A-II preproprotein | |
---|---|
Refseq ID | NP_001634 |
Protein GI | 4502149 |
UniProt ID | P02652 |
mRNA ID | NM_001643 |
Length | 100 |
RefSeq Status | REVIEWED |
MKLLAATVLLLTICSLEGALVRRQAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ | |
sig_peptide: 1..18 inference: COORDINATES: ab initio prediction:SignalP:4.0 calculated_mol_wt: 1889 peptide sequence: MKLLAATVLLLTICSLEG mat_peptide: 24..100 product: apolipoprotein A-II calculated_mol_wt: 8708 peptide sequence: QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ |
Gene Information
Gene Ontology (GO Annotations)
GO ID | Source | Type | Description |
---|---|---|---|
GO:0072562 | IDA:UniProt | C | blood microparticle |
GO:0042627 | IDA:BHF-UCL | C | chylomicron |
GO:0005829 | TAS:Reactome | C | cytosol |
GO:0005769 | TAS:Reactome | C | early endosome |
GO:0005788 | TAS:Reactome | C | endoplasmic reticulum lumen |
GO:0005576 | NAS:UniProtKB | C | extracellular region |
GO:0070062 | IDA:UniProtKB | C | extracellular vesicular exosome |
GO:0034364 | IDA:BHF-UCL | C | high-density lipoprotein particle |
GO:0034366 | IDA:BHF-UCL | C | spherical high-density lipoprotein particle |
GO:0034361 | IDA:BHF-UCL | C | very-low-density lipoprotein particle |
GO:0034190 | IPI:BHF-UCL | F | apolipoprotein receptor binding |
GO:0015485 | IDA:BHF-UCL | F | cholesterol binding |
GO:0017127 | IEA:Ensembl | F | cholesterol transporter activity |
GO:0008035 | IEA:Ensembl | F | high-density lipoprotein particle binding |
GO:0070653 | IPI:BHF-UCL | F | high-density lipoprotein particle receptor binding |
GO:0055102 | IDA:BHF-UCL | F | lipase inhibitor activity |
GO:0008289 | IDA:BHF-UCL | F | lipid binding |
GO:0005319 | IDA:BHF-UCL | F | lipid transporter activity |
GO:0031210 | IDA:BHF-UCL | F | phosphatidylcholine binding |
GO:0060228 | IDA:BHF-UCL | F | phosphatidylcholine-sterol O-acyltransferase activator activity |
GO:0005543 | IDA:BHF-UCL | F | phospholipid binding |
GO:0046982 | IPI:UniProtKB | F | protein heterodimerization activity |
GO:0042803 | IDA:BHF-UCL | F | protein homodimerization activity |
GO:0002526 | IEA:Ensembl | P | acute inflammatory response |
GO:0044255 | TAS:Reactome | P | cellular lipid metabolic process |
GO:0033344 | IDA:BHF-UCL | P | cholesterol efflux |
GO:0042632 | IDA:BHF-UCL | P | cholesterol homeostasis |
GO:0008203 | IEA:Ensembl | P | cholesterol metabolic process |
GO:0046340 | IDA:BHF-UCL | P | diacylglycerol catabolic process |
GO:0034380 | IDA:BHF-UCL | P | high-density lipoprotein particle assembly |
GO:0034384 | IDA:BHF-UCL | P | high-density lipoprotein particle clearance |
GO:0034375 | IDA:BHF-UCL | P | high-density lipoprotein particle remodeling |
GO:0042157 | TAS:Reactome | P | lipoprotein metabolic process |
GO:0034374 | IDA:BHF-UCL | P | low-density lipoprotein particle remodeling |
GO:0060621 | IDA:BHF-UCL | P | negative regulation of cholesterol import |
GO:0032375 | IMP:BHF-UCL | P | negative regulation of cholesterol transport |
GO:0060695 | IDA:BHF-UCL | P | negative regulation of cholesterol transporter activity |
GO:0002740 | IDA:BHF-UCL | P | negative regulation of cytokine secretion involved in immune response |
GO:0060192 | IDA:BHF-UCL | P | negative regulation of lipase activity |
GO:0050995 | IDA:BHF-UCL | P | negative regulation of lipid catabolic process |
GO:0010903 | IDA:BHF-UCL | P | negative regulation of very-low-density lipoprotein particle remodeling |
GO:0031100 | IEA:Ensembl | P | organ regeneration |
GO:0018206 | IDA:UniProtKB | P | peptidyl-methionine modification |
GO:0006656 | IDA:BHF-UCL | P | phosphatidylcholine biosynthetic process |
GO:0009395 | IDA:BHF-UCL | P | phospholipid catabolic process |
GO:0033700 | IDA:BHF-UCL | P | phospholipid efflux |
GO:0007603 | TAS:Reactome | P | phototransduction, visible light |
GO:0043085 | IDA:GOC | P | positive regulation of catalytic activity |
GO:0010873 | IDA:BHF-UCL | P | positive regulation of cholesterol esterification |
GO:0045416 | IDA:UniProtKB | P | positive regulation of interleukin-8 biosynthetic process |
GO:0050996 | IDA:BHF-UCL | P | positive regulation of lipid catabolic process |
GO:0006457 | IDA:BHF-UCL | P | protein folding |
GO:0018158 | IDA:UniProtKB | P | protein oxidation |
GO:0030300 | IEA:Ensembl | P | regulation of intestinal cholesterol absorption |
GO:0031647 | IDA:BHF-UCL | P | regulation of protein stability |
GO:0042493 | IEA:Ensembl | P | response to drug |
GO:0043627 | IEA:Ensembl | P | response to estrogen |
GO:0051384 | IEA:Ensembl | P | response to glucocorticoid |
GO:0009749 | IDA:BHF-UCL | P | response to glucose |
GO:0001523 | TAS:Reactome | P | retinoid metabolic process |
GO:0043691 | IDA:BHF-UCL | P | reverse cholesterol transport |
GO:0044281 | TAS:Reactome | P | small molecule metabolic process |
GO:0006641 | TAS:BHF-UCL | P | triglyceride metabolic process |
GO:0034370 | IDA:BHF-UCL | P | triglyceride-rich lipoprotein particle remodeling |
GO:0016032 | IEA:UniProtKB-KW | P | viral process |
KEGG Pathway Links
KEGG Pathway ID | Description |
---|---|
hsa03320 | PPAR signaling pathway |
REACTOME Pathway Links
REACTOME Pathway ID | Description |
---|---|
REACT_116145 | PPARA activates gene expression |
Domain Information
InterPro Annotations
Accession | Description |
---|---|
IPR006801 | Apolipoprotein A-II (ApoA-II) |
UniProt Annotations
Entry Information
Comments
Comment Type | Description |
---|---|
Function | May stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism. |
Mass Spectrometry | Mass=17166.2; Method=MALDI; Range=24-99; Note=Homodimer.; Evidence= ; |
Mass Spectrometry | Mass=17252; Method=Electrospray; Range=24-100; Note=Homodimer, without methionine sulfoxide.; Evidence= ; |
Mass Spectrometry | Mass=17269; Method=Electrospray; Range=24-100; Note=Homodimer, with 1 methionine sulfoxide, oxidation at Met-49.; Evidence= ; |
Mass Spectrometry | Mass=17293.4; Method=MALDI; Range=24-100; Note=Heterodimer with truncated apolipoprotein A-II.; Evidence= ; |
Mass Spectrometry | Mass=17421.3; Method=MALDI; Range=24-100; Note=Homodimer.; Evidence= ; |
Mass Spectrometry | Mass=8578.3; Method=MALDI; Range=24-99; Evidence= ; |
Mass Spectrometry | Mass=8701.2; Method=MALDI; Range=24-100; Evidence= ; |
Mass Spectrometry | Mass=8823.4; Method=MALDI; Range=24-100; Note=Cysteinylated ApoA-II.; Evidence= ; |
Polymorphism | A homozygous transition at position 1 of intron 3 of APOA2 results in deficiency of apolipoprotein A-II, without significant influence either on lipid and lipoprotein profiles or on the occurrence of coronary artery disease [MIM |
Ptm | Apolipoprotein A-II is O-glycosylated. |
Ptm | Phosphorylation sites are present in the extracellular medium. |
Similarity | Belongs to the apolipoprotein A2 family. |
Subcellular Location | Secreted. |
Subunit | Homodimer; disulfide-linked. Also forms a disulfide- linked heterodimer with APOD. Interacts with HCV core protein. Interacts with APOA1BP and NDRG1. {ECO |
Tissue Specificity | Plasma; synthesized in the liver and intestine. |
Web Resource | Name=SHMPD; Note=The Singapore human mutation and polymorphism database; URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=APOA2"; |
Identical and Related Proteins
Unique RefSeq proteins for LMP000398 (as displayed in Record Overview)
Protein GI | Database | Accession | Length | Protein Name |
---|---|---|---|---|
4502149 | RefSeq | NP_001634 | 100 | apolipoprotein A-II preproprotein |
Identical Sequences to LMP000398 proteins
Reference | Database | Accession | Length | Protein Name |
---|---|---|---|---|
GI:4502149 | GenBank | AGM57155.1 | 100 | Sequence 171 from patent US 8420337 |
GI:4502149 | GenBank | AGP16939.1 | 100 | Sequence 2 from patent US 8460889 |
GI:4502149 | GenBank | AHE01108.1 | 100 | Sequence 56024 from patent US 8586006 |
GI:4502149 | GenBank | AIC48277.1 | 100 | APOA2, partial [synthetic construct] |
GI:4502149 | RefSeq | XP_004027815.1 | 100 | PREDICTED: apolipoprotein A-II [Gorilla gorilla gorilla] |
GI:4502149 | RefSeq | XP_004027816.1 | 100 | PREDICTED: apolipoprotein A-II [Gorilla gorilla gorilla] |
Related Sequences to LMP000398 proteins
Reference | Database | Accession | Length | Protein Name |
---|---|---|---|---|
GI:4502149 | GenBank | AAP36148.1 | 101 | Homo sapiens apolipoprotein A-II, partial [synthetic construct] |
GI:4502149 | GenBank | AAX29455.1 | 101 | apolipoprotein A-II, partial [synthetic construct] |
GI:4502149 | GenBank | AAX29456.1 | 101 | apolipoprotein A-II, partial [synthetic construct] |
GI:4502149 | GenBank | AGB62517.1 | 153 | Sequence 78 from patent US 8288091 |
GI:4502149 | GenBank | AGB62523.1 | 120 | Sequence 84 from patent US 8288091 |
GI:4502149 | RefSeq | XP_004027817.1 | 133 | PREDICTED: apolipoprotein A-II [Gorilla gorilla gorilla] |